Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
Funding for developing interdisciplinary research infrastructure in aging studies to address key research questions, with 2 years of initial support and 3 years for expanded activities using the NIH R61/R33 mechanism.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: July 2, 2025 (New) | August 4, 2025 (Renewal/Resubmission/Revision) | November 3, 2025 (New) | December 2, 2025 (Renewal/Resubmission/Revision)
Funding Amounts: Up to $500,000 direct costs/year for each phase; R61 phase (up to 2 years), R33 phase (up to 3 years); max 5 years total.
Summary: Supports development of novel interdisciplinary research infrastructure to advance aging science, using a two-phase R61/R33 mechanism.
Key Information: Both R61 and R33 phases must be proposed; annual direct costs must remain under $500,000; clinical trials are optional.
Description
This opportunity from the National Institutes of Health (NIH), led by the National Institute on Aging (NIA) and co-funded by the Office of Research on Women's Health (ORWH), supports the development of innovative research infrastructure to advance interdisciplinary aging research. The program uses the NIH R61/R33 phased innovation award mechanism, providing up to 2 years for initial development (R61) and up to 3 years for expanded activities (R33). The goal is to create sustainable infrastructure that enables new collaborations and addresses key research questions in aging, ultimately benefiting the broader research community.
Projects must propose both an R61 and an R33 phase, with clear, milestone-driven plans for each. The infrastructure developed should support interdisciplinary research and generate new knowledge, tools, or resources that extend beyond the applicant’s own interests.
